MapLight Therapeutics, Inc. MPLT Proceeds from issuance of preferred stock
Proceeds from issuance of preferred stock at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock.
The official record: MapLight Therapeutics, Inc. ’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about MapLight Therapeutics, Inc. 's proceeds from issuance of preferred stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MapLight Therapeutics, Inc. 's proceeds from issuance of preferred stock?
- MapLight Therapeutics, Inc. (MPLT) reported proceeds from issuance of preferred stock of $49.71M in Q4 2025.
- What does proceeds from issuance of preferred stock mean?
- Cash received from issuing preferred stock — hybrid equity that provides fixed dividends without common stock dilution.